欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CY/H/0138/003
药品名称
Rosuvastatin + Ezetimibe RAFARM
活性成分
ezetimibe 10.0 mg
rosuvastatin 20.0 mg
剂型
Tablet
上市许可持有人
RAFARM S.A. 12 Korinthou str., N. Psihiko 154 51 Athens Greece
参考成员国 - 产品名称
Cyprus (CY)
互认成员国 - 产品名称
Greece (GR)
许可日期
2020/03/24
最近更新日期
2024/06/24
药物ATC编码
C10BA06 rosuvastatin and ezetimibe
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
AR _ Public Assessment Report
Date of last change:2024/09/06
Final Labelling
|
common_labelling
Date of last change:2024/09/06
Final PL
|
common_pil_track
Date of last change:2024/09/06
Final SPC
|
common_spc_track
Date of last change:2024/09/06
PubAR Summary
|
Summary non_generics template
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase